Stem cell therapy vs peripheral therapy with granulocyte colony‐stimulating factorPerformance status – functional class (NYHA) · DCM (non‐ischaemic)1 finding from 1 reviewStem cell therapy for dilated cardiomyopathy 2021 · Cochrane Headline outcomes onlyno estimate extracted0 studies · 0 participantsGRADE not reported